CoChat

Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia

Open access
Bitanihirwe, BKY, Lim, MP, Kelley, JF, Kaneko, T, Woo, TUW · 2009 · BMC Psychiatry

The DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.

Abstract

Background: We have previously reported that the expression of the messenger ribonucleic acid (mRNA) for the NR2A subunit of the N-methyl-D-aspartate (NMDA) class of glutamate receptor was decreased in a subset of inhibitory interneurons in the cerebral cortex in schizophrenia. In this study, we sought to determine whether a deficit in the expression of NR2A mRNA was present in the subset of interneurons that contain the calcium buffer parvalbumin (PV) and whether this deficit was associated with a reduction in glutamatergic inputs in the prefrontal cortex (PFC) in schizophrenia. Methods: We examined the expression of NR2A mRNA, labeled with a 35 S-tagged riboprobe, in neurons that expressed PV mRNA, visualized with a digoxigenin-labeled riboprobe via an immunoperoxidase reaction, in twenty schizophrenia and twenty matched normal control subjects. We also immunohistochemically labeled the glutamatergic axon terminals with an antibody against vGluT1. Results: The density of the PV neurons that expressed NR2A mRNA was significantly decreased by 48-50% in layers 3 and 4 in the subjects with schizophrenia, but the cellular expression of NR2A mRNA in the PV neurons that exhibited a detectable level of this transcript was unchanged. In addition, the density of vGluT1-immunoreactive boutons was significantly decreased by 79% in layer 3, but was unchanged in layer 5 of the PFC in schizophrenia. Conclusion: These findings suggest that glutamatergic neurotransmission via NR2A-containing NMDA receptors on PV neurons in the PFC may be deficient in schizophrenia. This may disinhibit the postsynaptic excitatory circuits, contributing to neuronal injury, aberrant information flow and PFC functional deficits in schizophrenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-244x-9-71

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Plots of PV+/NR2A+ neurons from representative sections from a normal control (A) and a schizophrenia subject (B). Numbers depict cortical layers. X = PV mRNA-expressing neurons. O = PV neurons that co-express NR2A mRNA
Figure 1 Plots of PV+/NR2A+ neurons from representative sections from a normal control (A) and a schizophrenia subject (B). Numbers depict cortical layers. X = PV mRNA-expressing neurons. O = PV neurons that co-express NR2A mRNACC BY · PubMed Central
Figure 2 (A) Photomicrograph showing examples of PV+/NR2A+ neurons. Scale bar = 20 μm. (B) Mean (± SEM) density of PV+/NR2A+ neurons is significantly decreased in layers 3 and 4 in the PFC in schizophrenia.
Figure 2 (A) Photomicrograph showing examples of PV+/NR2A+ neurons. Scale bar = 20 μm. (B) Mean (± SEM) density of PV+/NR2A+ neurons is significantly decreased in layers 3 and 4 in the PFC in schizophrenia.CC BY · PubMed Central
Figure 3 Mean (± SEM) density of silver grains over PV+ neurons in the PFC is not different between the two subject groups, suggesting that the expression level of NR2A mRNA in PV cells is unchanged in schizophrenia.
Figure 3 Mean (± SEM) density of silver grains over PV+ neurons in the PFC is not different between the two subject groups, suggesting that the expression level of NR2A mRNA in PV cells is unchanged in schizophrenia.CC BY · PubMed Central
Figure 4 (A) Photomicrographs showing vGluT1-immunoreactive boutons in layer 3 of the PFC. Scale bar = 100 μm. (B) Density of vGluT1-immunoreactive boutons is significantly decreased in layer 3 of the PFC in schizophrenia.
Figure 4 (A) Photomicrographs showing vGluT1-immunoreactive boutons in layer 3 of the PFC. Scale bar = 100 μm. (B) Density of vGluT1-immunoreactive boutons is significantly decreased in layer 3 of the PFC in schizophrenia.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Research works printed but not linked: 1

  1. Baddeley AD: Working memory. 1988, Oxford: Oxford University Press

Cited by

See all 137

Metadata

Authors
Bitanihirwe, B., Lim, M., Kelley, J., Kaneko, T., & Woo, T.
Affiliations
  • McLean Hospital (US)
  • Kyoto University (JP)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Woo, TUW
Venue
BMC Psychiatry
Published
2009-11-16
Volume
9
Issue
1
Pages
71-71
ISSN
1471-244X (ISSN-L)
OpenAlex
W2165329858
Cited by
137
References
92
Citations by year
2026: 6 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 3 · 2021: 7 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 7 · 2016: 7 · 2015: 9 · 2014: 13 · 2013: 17 · 2012: 7
FWCI
4.73
Type
journal article
Language
en
Open access
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (MH068541, R01MH076060, R03MH068541, MH076060)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
schizophrenia, parvalbumin interneurons, glutamatergic neurotransmission, prefrontal cortex, VGLUT1, inhibitory interneurons, disinhibition
MeSH terms
Cell Count, Digoxigenin, Humans, Immunohistochemistry, Interneurons, Neural Inhibition, Synaptic Transmission, Neurons, Parvalbumins, RNA, Messenger, Schizophrenia, Gene Expression, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. https://app.cochat.ai/papers/10.1186/1471-244x-9-71
The paper
Bitanihirwe, B., Lim, M., Kelley, J., Kaneko, T., & Woo, T. (2009). Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry. https://doi.org/10.1186/1471-244x-9-71

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.